Devens, MA, USA — Veranova, a global leader in the development and manufacturing of specialist and complex active pharmaceutical ingredients (APIs) for the pharmaceutical and biotech sectors, today announced a strategic investment to establish state-of-the-art bioconjugation development and cGMP manufacturing capacity at its Devens, Massachusetts campus.
When the goal is growth, building a scalable lab ops tech stack is critical. In a recent webinar, Joel Basken, Director of Operations, and Nicolette Surges, Lab Manager at Enveda Bioscience, a startup based in Colorado, shared invaluable insights and lessons on optimizing lab operations for scalability.
Enveda’s story: A real-life example of a scalable tech stack
The right tech stack for each startup varies, but Enveda has found success with the following solutions:
Department for Business and Trade (DBT) Japan are delighted to host the 5th webinar inviting speakers from the leading 5 Japanese pharmaceutical companies: Astellas Europe Ltd, Daiichi Sankyo Co Ltd, Eisai Co Ltd, Shionogi & Co Ltd and Takeda Pharmaceutical Company Limited to present their latest R&D collaboration wish list.
This webinar will provide an ideal opportunity for the UK companies / academia looking to learn the latest research priorities and collaboration structures of the leading Japanese pharmaceutical companies.
As global companies compete fiercely for top-tier talent, those with a foothold in Cambridge now have an unprecedented advantage: corporate housing designed specifically to attract and retain the best. Present Made, Eddington, is leading the way with Cambridge’s first purpose-built, large-scale corporate letting scheme – a pioneering development that brings 21st-century executive living to one of the UK’s most dynamic science and technology hubs.
We are looking for a motivated and talented postdoctoral-level researcher with experience in executable modelling to join a cutting-edge project developing Digital Twins for rare diseases. This is a unique opportunity to work at the intersection of systems biology, AI, and translational research, and to contribute to open science through the Chan Zuckerberg Initiative.
Your group
Petsalaki Group, in collaboration with Open Targets and BioModels teams.
With the recent wave of US tariffs, UK businesses trading internationally face mounting cost pressures. For tech and life sciences companies, especially those sourcing physical goods from China and exporting to the US, these changes could significantly impact profitability and competitiveness.
Join us for an exclusive webinar hosted by Frazier & Deeter where our international tax and trade experts will explore how UK companies can manage tariff exposure
Speakers Include:
Five new ventures secure the chance to be part of Babraham Research Campus - a leading location for early-stage life science start-ups
Your strategy is ambitious. Your people are brilliant. But progress is slow. Why? Because your teams are overwhelmed with collaboration: meetings that don’t move things forward, bloated decision-making processes and a web of information and messages.
Most companies (even new ones!) are still running on industrial-era collaboration habits where meetings are the default modality, overwhelm is normal and progress requires too many people in too many conversations.
In the knowledge era, collaboration needs a new operating system - one with less friction and more flow.